Suzhou Highfine Biotech is committed to serving the front-end process of new drug R&D with the aim of catering to customer needs.The scope of products covers coupling reagents consisting of characteristic amide bonds, building blocks, protein reagents, Ionic liquids, PROTAC reagents, unnatural amino acids, pharmaceutical reagents of liposomes and lipid nanoparticles, and Nucleotide reagents, etc.


High Quality, Fine Efficiency

By keeping up with the global R&D trend of innovative drugs and the market demand of CRO and CMO companies at home and abroad, we can provide highly cost-effective products for customers from all over the world and facilitate the global R&D and production of new drugs  with a wholly owned subsidiary Suzhou Highfine Import & Export Co., Ltd. in Nov 2021 as the main body of the company's import and export business.


Suzhou Highfine Biotech Co., Ltd.(stock code: 301393), established in 2003, is located in Suzhou High-tech Industrial Development Zone. It is a high-tech enterprise in Jiangsu province and provides characteristic chemicals for global pharmaceutical R&D and production companies. Our products are mainly used in the fields of polypeptide, nucleotide and pharmaceutical synthesis. At present, more than 1500 kinds of products have been developed and produced.


Anhui Highfine Biotech Co., Ltd. is located in the high-tech zone of Anqing. It was established in September 2018 with a registered capital of 100 million RMB. It is a subsidiary of Suzhou Highfine Biotech Co., Ltd. Covering an area of 59,000 m2, with a total investment of 300 million RMB, it was completed and put into operation in 2021. There are comprehensive office buildings, research and development centers, 3 production workshops, raw materials and finished products warehouses and other facilities. DCS automatic control system improves production efficiency and safety. It is mainly used to carry out the projects of peptide reagents and protein cross-linking agents.